key: cord-0259361-xrw79bvo
authors: Al-Mamun, M. A.; Strock, J.; Sharker, Y.; Schmidt, R.; Shawwa, K.; Slain, D.; Sakhuja, A.; Brothers, T.
title: Evaluating the Association and Predictability of Complex Medication Regimen Scores with Clinical Outcomes Among the Critically Ill
date: 2022-02-04
journal: nan
DOI: 10.1101/2022.02.03.22270376
sha: e280761d1f4ec996272797c50c34b445bf32146b
doc_id: 259361
cord_uid: xrw79bvo

Introduction Medication Regimen Complexity (MRC) refers to the combination of medication classes, dosages, and frequencies. The relationship between MRC and clinical outcomes in the intensive care unit (ICU) has not been examined. The objective of this study is to examine the association between MRC scoring tools and their utility in predicting clinical outcomes. Methods We conducted a retrospective cohort study that includes 322 adult patients admitted and stayed (>24 hours) to the ICU between February 1, 2020, and August 30, 2020 in a community-based, teaching hospital in Rhode Island .Medication complexity was assessed using two MRC scoring tools: MRC Index (MRCI) and the MRC in ICU (MRCICU). We used a multivariable logistic regression model to identify the association between MRC scores and clinical outcomes and to predict the clinical outcomes. RESULTS Among the 317 patients included in the study (55.2% men with a median age of 62 [IQR: 51-75] years). Higher MRC scores (i.e., > 63 MRCI or > 6 MRCICU) were associated with increased mortality (14% and 15%), longer ICU length of stay (LOS )(30% and 34%), and need for MV (24% and 28%). MRCICU scores at 24 hours were found to be a significant risk factor in all clinical outcomes (ICU mortality, LOS, and MV) with Odds Ratio (ORs) of 1.12 (95% CI: 1.06-1.19), 1.17 (1.1- 1.24), and 1.21 (1.14- 1.29), respectively. In the prediction models, both MRCI and MRCICU models performed similarly (AUC: 0.88 [0.75-0.97] and 0.88 [0.76-0.97] in predicting mortality. The Medication Model included 15 medication classes outperformed others (AUC: 0.82 [0.71-0.93] in predicting ICU LOS and the MRCICU model outperformed others (AUC: 0.87 [0.77-0.96]) in predicting the need for MV. CONCLUSION MRC scores are associated with poorer clinical outcomes and improves the prediction of poorer clinical outcomes which will support clinicians to prescribe safer therapies.

Medication regimen complexity (MRC) refers to multiple features of a patient's medication drug 64 regimen rather than absolute number of medications consumed per day [1] . MRC incorporates features 65 such as the number of agents, dosages, administration time intervals, and additional instructions (i.e., 66 take on an empty stomach) [2] [3] [4] . An increase in MRC burden has been associated with poorer 67 medication noncompliance and caregiver quality of life measures, as well as an increase in healthcare 68 resource utilization [5, 6] . Critically ill patients are at significant risk of higher MRC due to the severity of 69 illness, management of multiple chronic conditions, and the complex pharmacotherapies prescribed. It 70 has been estimated that the average critically ill adult may receive up to 13 medications per day and the 71 incidence of experiencing an adverse drug event has been estimated to greater than 25% lending to 72 substantial morbidity and mortality [7] [8] [9] [10] [11] . Therefore, examining only the quantity of medications 73 administered may not accurately describe the complex and intricate nature of the critical care 74 medication regimens.

Numerous methods have been used to quantify the complexity of medication regimens. Yet, the most 76 commonly utilized and validated objective scoring tool is the 65-item, weighted MRC index (MRCI) which 77 has been developed for outpatient use [12] [13] [14] [15] [16] . MRCI has been used to evaluate conditions such as 78 neurological impairment in children, hypertension, diabetes, and chronic kidney disease in adults [17-79 21] . In the intensive care unit (ICU) population, the MRC in ICU (MRCICU) scoring tool was developed 80

and revised (modified MRCICU) in 2019 [22, 23] . The modified MRCICU is the first validated quantitative 81 weighted scoring tool intended to predict clinical outcomes (i.e., ICU mortality, length of stay (LOS), and 82 need for mechanical ventilation (MV)) [24, 25] . In a previous study, we have developed a novel proof-of-83 concept method demonstrating improvement in the prediction of patient outcomes by incorporating 84 the MRCICU score into the previously established Acute Physiology and Chronic Health Evaluation 85 (APACHE II) scoring tool [26] . To date, no study has assessed the association between these two MRC 86 scoring tools and clinical outcomes within the critical care setting.

In this study, we developed two custom MRC scoring algorithms and several statistical and prediction 88 models using the MRCI and MRCICU tools to gain insight into how MRC impacts clinical outcomes (i.e., 89 ICU mortality, LOS, and need for MV). We aimed to (1) logistic regression models were utilized to examine the association between risk factors and clinical . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) prediction models were constructed without any variable selection. A 'no imputation' approach was 152 used when preparing the data for the prediction model. We assessed correlated variables using the 153

Pearson correlation coefficient. The SAPS II severity score was used in the prediction models due to a 154 high correlation with the APACHE II classification system (S1 Fig) . The prediction accuracy was evaluated 155 using the area under the receiver operating characteristic (AUC) curve. An AUC of at least 0.7 was 156 regarded as acceptable. We applied a 'leave-one-out' cross-validation method with 10,000 repetitions 157 and AUC was selected as an overall performance measure. Additionally, sensitivity and specificity 158 analyses were included for the three outcomes. Furthermore, all prediction models recorded variable 159 importance rankings for each outcome. characteristics between survivors and non-survivors . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted February 4, 2022. Table) . The use of vasopressors was found to be a significant risk factor for all 210 outcomes in the models. When evaluating morality, the use of paralytic agents was significant with an 211 (OR: 3.38 (1.09-11.11). The use of anti-infectives, anticoagulants, and cardiovascular agents were 212 significantly associated with prolonged LOS. Lastly, the use of analgesics, sedatives, psychiatric, 213 cardiovascular, and pulmonary agents were significant risk factors for the need of MV.

214 215 216 is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted February 4, 2022. (Fig 2) . In the MRCI & SAPS II Model, MRCI scores at 24 and 48 231 hours were identified as the top variables of importance when predicting mortality (Fig 3) . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted February 4, 2022. ; . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted February 4, 2022. interdisciplinary care team members to review and modify the medication regimen to ensure safer, . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted February 4, 2022. ; https://doi.org/10.1101 https://doi.org/10. /2022 278 patient-centered care [41] [42] [43] [44] . This study corroborates the need of standardizing MRC scores within the 279 critically ill population.

Secondly, our results clearly demonstrate that MRC scores at 24 hours were associated with mortality 281 suggesting they should be incorporated into current practice ( MRC has been shown to be a better predictor of mortality compared to polypharmacy alone [32] . MRC 284 scores at 24 hours were significantly associated with ICU LOS and the incorporation of therapeutic drug 285 classes improved the prediction for LOS and need for MV (Table 3) . These findings can be confounded 286 however by a) exclusion of the weights for important medications (i.e., vasopressors and anti-infectives) 287

in MRC calculations, b) exclusion of patient's severity, and c) exclusion of influential combinations of 288 medications regimens.

Thirdly, vasopressors were a significant predictor in all clinical outcome models (Fig 3) and were found 290

to be statistically significant in all stepwise models ( Table 2 ). In practice, use of vasopressors is indicated 291

in patients with poorer health conditions, such as decompensated heart failure and shock [45, 46] . The 292 frequent diagnosis of ICU-related delirium has been a known contributing factor to ICU LOS among other 293 undesirable outcomes [47] [48] [49] . Historically, numerous medications have been used to minimize the 294 duration of delirium, yet studies are lacking to identify a safe and effective agent. Our findings of current 295 psychiatric medications potentially contributing to an increase in TOMV suggests the continued need to 296

identify an agent to minimize the incidence and duration of ICU delirium leading to extended TOMV and 297

LOS.

Lastly, the association of pulmonary and paralytic agent use with mortality and the need for MV was 299 anticipated in our findings as these therapeutic classes are commonly associated with high acuity 300 diseases such as acute respiratory distress syndrome (ARDS) and acute brain injury [50, 51] . Therefore, 301

our study supports the inclusion of medication class usage to predict critically ill outcomes. Most 302

notably, the lack of medication use into existing severity of illness scoring tools ( We propose adopting MRC scores, preexisting comorbidities, and severity of illness into future modeling 316

to improve the accuracy of prediction. 317 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted February 4, 2022. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted February 4, 2022. ; https://doi.org/10.1101/2022.02.03.22270376 doi: medRxiv preprint

Development and Validation of the 361 Medication Regimen Complexity Index Pharmacoepidemiology

What is polypharmacy? A systematic review of 364 definitions

Defining polypharmacy in 366 the elderly: a systematic review protocol

Polypharmacy in older adults: a narrative review of definitions, 369 epidemiology and consequences. European geriatric medicine

Complexity 372 perplexity: a systematic review to describe the measurement of medication regimen complexity. 373 Expert opinion on drug safety

Medication 375 Regimen Complexity Measured by MRCI: A Systematic Review to Identify Health Outcomes

An interventional study 378 on intensive care unit drug therapy assessment in a rural district hospital in India

Connections/Archives/2019/Standard-Medication-Concentrations-An-Opportunity

The Critical Care 389 Safety Study: The incidence and nature of adverse events and serious medical errors in intensive 390 care

Medication regimen complexity 392 and readmissions after hospitalization for heart failure, acute myocardial infarction, pneumonia, 393 and chronic obstructive pulmonary disease

Discharge medication complexity and 30-396 day heart failure readmissions

Medication regimen complexity and hospital readmission for an 399 adverse drug event. The Annals of pharmacotherapy

Development and validation of the 402 Korean version of the medication regimen complexity index

Nonadherence to Medication 405 Therapy in Haemodialysis Patients: A Systematic Review

Changes Over Time in the Drug Burden and Medication Regimen Complexity in ESRD Patients 409 Before and After Renal Transplantation

Medication 413

Regimen Complexity and Hospital Readmission in Older Adults With Chronic Kidney Disease. The 414 Annals of pharmacotherapy

Medication regimen complexity and its impact on 416 medication adherence and glycemic control among patients with type 2 diabetes mellitus in an 417 Ethiopian general hospital

Effect of number of medications and complexity of 420 regimens on medication adherence and blood pressure management in hospitalized patients 421 with hypertension

Is guideline-423 adherent prescribing associated with quality of life in patients with type 2 diabetes?

Characterization of changes in medication 426 complexity using a modified scoring tool

Development and validation of a medication 429 regimen complexity scoring tool for critically ill patients

A survey of critical 433 care pharmacists to patient ratios and practice characteristics in intensive care units

Multicenter validation of a novel medication-436 regimen complexity scoring tool

Development of Machine Learning Models to Validate a 439

Medication Regimen Complexity Scoring Tool for Critically Ill Patients. The Annals of 440 pharmacotherapy

Characterization of changes in medication 442 complexity using a modified scoring tool

R: The R Project for Statistical Computing

Elegant Graphics for Data Analysis Using the 450 Grammar of Graphics

Predicting potential postdischarge 452 adverse drug events and 30-day unplanned hospital readmissions from medication regimen 453 complexity

Medication Regimen Complexity and 455 Number of Medications as Factors Associated With Unplanned Hospitalizations in Older People: 456 A Population-based Cohort Study

Medication transitions and 459 polypharmacy in older adults following acute care

Medication Regimen 462 Complexity and Unplanned Hospital Readmissions in Older People. The Annals of 463 pharmacotherapy

Medication 465 nonadherence and subsequent risk of hospitalisation and mortality among older adults. Drugs 466 and Aging

Relationship Between ICU Length of Stay and

Long-Term Mortality for Elderly ICU Survivors

Long-term 471 outcome in ICU patients with acute kidney injury treated with renal replacement therapy: a 472 prospective cohort study

The outcomes and prognostic 475 factors of patients requiring prolonged mechanical ventilation

Impact of a clinical pharmacist-enforced intensive care unit 478 sedation protocol on duration of mechanical ventilation and hospital stay

Care Resources in COVID-19 An Implementation Guide for Regional Allocation: An Expert Panel 482 Report of the Task Force for Mass Critical Care and the

Diagnostic accuracy and effectiveness of automated 485 electronic sepsis alert systems: A systematic review

A systematic review of the effectiveness of interruptive 488 medication prescribing alerts in hospital CPOE systems to change prescriber behavior and 489 improve patient safety

Effect of clinical decision-492 support systems: a systematic review

Effects of clinical decision-support systems 495 on practitioner performance and patient outcomes: a synthesis of high-quality systematic review 496 findings

Surviving sepsis 499 campaign: international guidelines for management of sepsis and septic shock 2021. Intensive 500 care medicine

Inotropes and vasopressors use in cardiogenic shock: when, which 502 and how much? Current opinion in critical care

Impact of early home psychotropic 505 medication reinitiation on surrogate measures of intensive care unit delirium. The mental health 506 clinician

Clinical 508 Practice Guidelines for the Prevention and Management of Pain, Agitation/Sedation, Delirium

Sleep Disruption in Adult Patients in the ICU

Delirium duration and 512 mortality in lightly sedated, mechanically ventilated intensive care patients. Critical care 513 medicine

Sustained Neuromuscular Blockade in the Adult Critically Ill Patient

Critical care delivery in 521 the intensive care unit: defining clinical roles and the best practice model

Position Paper on Critical Care 524 Pharmacy Services: 2020 Update

Pharmacists Are Associated With Reduced Mortality in 527 Critically Ill Patients

Are 530 Clinical Outcomes Associated With Medication Regimen Complexity? A Systematic Review

The Annals of pharmacotherapy

. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to (which was not certified by peer review)